Key result
Higher E-sdLDL-C linked to ~44% higher incident MI risk in dialysis patients.
Why the study?
Small dense LDL-C is an atherogenic subfraction that may reflect coronary risk beyond conventional cholesterol levels, and can be estimated from a standard lipid panel. However, the prognostic relevance of estimated sdLDL-C for myocardial infarction in patients undergoing dialysis remained uncertain.
Is higher estimated small dense low-density lipoprotein cholesterol (E-sdLDL-C) associated with incident myocardial infarction and ischemic stroke in patients with end-stage kidney disease undergoing long-term dialysis?
Cohort (n=21,671)
Yes
Is higher estimated small dense low-density lipoprotein cholesterol (E-sdLDL-C) associated with incident myocardial infarction and ischemic stroke in patients with end-stage kidney disease undergoing long-term dialysis?
In patients with end-stage kidney disease on long-term dialysis, higher estimated sdLDL-C is independently associated with an increased risk of incident myocardial infarction—but not ischemic stroke—providing complementary coronary risk stratification information alongside conventional lipid measures.
Answers are grounded in this paper and cite their sources.
Estimated sdLDL-C should not yet guide MI risk management in dialysis; leaves open its incremental prognostic value in ESKD.
Small dense low-density lipoprotein cholesterol (sdLDL-C) is an atherogenic LDL subfraction that may reflect lipid-related coronary risk beyond conventional cholesterol levels. Estimated sdLDL-C (E-sdLDL-C) is calculated from a standard lipid panel, but its prognostic relevance for myocardial infarction in patients undergoing dialysis remains uncertain. This nationwide cohort study included 21,671 adults with end-stage kidney disease (ESKD) receiving long-term dialysis who underwent health screening in 2009–2017. E-sdLDL-C was calculated from fasting lipid profiles and categorised into quartiles. Incident myocardial infarction and ischemic stroke were the primary and secondary outcomes, respectively, assessed through December 2022. During 166,428 person-years, 993 myocardial infarctions occurred, with 9,426 deaths before myocardial infarction. Fully adjusted hazard ratios for myocardial infarction in Quartiles 2–4 versus Quartile 1 were 1.24 (95% CI, 1.01–1.52), 1.61 (1.32–1.96), and 1.44 (1.15–1.80), respectively. The association remained significant after accounting for competing mortality. For ischemic stroke, 1,249 events and 9,254 competing deaths occurred during 165,727 person-years, with no significant association with E-sdLDL-C after full adjustment. Adding E-sdLDL-C increased the C-index for myocardial infarction from 0.716 to 0.726 (Δ = 0.010), without significant differences from models including LDL-C (0.725; p = 0.453) or non-HDL-C (0.727; p = 0.264). Among patients undergoing long-term dialysis, E-sdLDL-C was associated with incident myocardial infarction after multivariable adjustment, whereas no significant association was observed with ischemic stroke. These findings support the potential relevance of E-sdLDL-C for myocardial infarction risk assessment in patients with ESKD, although its clinical utility requires further validation. Higher E-sdLDL-C was associated with incident myocardial infarction in patients undergoing long-term dialysis, even after adjustment for LDL-C.No significant association between E-sdLDL-C and ischemic stroke was observed after full adjustment.E-sdLDL-C may provide complementary information for coronary risk stratification in end-stage kidney disease, but it should not replace established lipid measures. Higher E-sdLDL-C was associated with incident myocardial infarction in patients undergoing long-term dialysis, even after adjustment for LDL-C. No significant association between E-sdLDL-C and ischemic stroke was observed after full adjustment. E-sdLDL-C may provide complementary information for coronary risk stratification in end-stage kidney disease, but it should not replace established lipid measures.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted a cohort in End-stage kidney disease (ESKD) receiving long-term dialysis (n=21,671). Higher estimated small dense low-density lipoprotein cholesterol (E-sdLDL-C) quartiles (Quartiles 2–4) vs. Lowest E-sdLDL-C quartile (Quartile 1) was evaluated on Incident myocardial infarction (HR 1.44, 95% CI 1.15-1.80). Higher E-sdLDL-C (Quartile 4 vs 1) was associated with increased incident myocardial infarction in dialysis patients.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: